ConductScience.org, home

Paper35192

Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.

Wallis TD and 4 others. Br J Clin Pharmacol, 1979. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate. Papers, record 35192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35192

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2019-05-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wallis TDT D
2Vallé-Jones JCJ C
3Craven JRJ R
4Hanks GWG W
5Stonier PDP D

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
AnxietyMajor topic
Clorazepate DipotassiumMajor topic
Adolescent
Adult
Age Factors
Clinical Trials as Topic
Double-Blind Method
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Sex Factors

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1241,987A single-dose anti-anxiety drug. A report from the General Practitioner Research Group.Practitioner1975https://conductscience.org/library/papers/241987PubMed
227,539Clobazam versus diazepam--a double-blind study in anxiety neurosis.J Clin Pharmacol1978https://conductscience.org/library/papers/27539PubMed
335,189Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice.Br J Clin Pharmacol1979https://conductscience.org/library/papers/35189PubMed
435,197Review of clinical studies on clobazam.Br J Clin Pharmacol1979https://conductscience.org/library/papers/35197PubMed
535,215Anxiety reduction and sedation: psychophysiological theory.Br J Clin Pharmacol1979https://conductscience.org/library/papers/35215PubMed
64,590,788Once-a-day potassium clorazepate in anxiety.Br J Clin Pract1973https://conductscience.org/library/papers/4590788PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
6,125,394Clobazam: single or divided doses?Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6125394PubMed
6,107,238Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.Drugs1980https://conductscience.org/library/papers/6107238PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35192

GET https://conductscience.org/api/papers/v1/35192/authors